<DOC>
	<DOCNO>NCT00953498</DOCNO>
	<brief_summary>HDL patient type 2 diabetes show significant reduction endothelium-dependent vasodilatory effect . The primary objective study analyze whether treatment glitazones ( pioglitazone rosiglitazone ) may improve endothelium-dependent vasodilatory effect HDL lipoproteins patient type 2 diabetes . The secondary objective : - analyze effect glitazone treatment phospholipase A2 - look possible difference effect pioglitazone rosiglitazone - analyze glycemic response glitazone therapy accord clinical biological baseline characteristic .</brief_summary>
	<brief_title>Influence Glitazones Vasodilatory Effect High-density Lipoprotein ( HDL ) Lipoproteins</brief_title>
	<detailed_description>The study perform follow : At baseline , initiate glitazone treatment , clinical data record blood sample obtain biological measurement ( blood glucose , HbA1c , total cholesterol , triglyceride , LDL-cholesterol , HDL-cholesterol , liver enzymes ) , phospholipase A2 measurement study vasodilatory effect HDL particles.For purpose , study , use rabbit aorta ring , ability HDL suppress inhibition vasodilation induce oxidised LDL . For patient include study , treatment pioglitazone ( initial dose 30 mg/day ) rosiglitazone ( initial dose 4 mg/day ) give randomization . A visit perform week 12 , order titrate glitazone dose ( 45 mg/day pioglitazone , 8 mg/day rosiglitazone ) accord HbA1c level value self-monitoring blood glucose . At week 24 , last visit take place . During visit , clinical data record blood sample obtain biological measurement ( blood glucose , HbA1c , total cholesterol , triglyceride , LDL-cholesterol , HDL-cholesterol , liver enzymes ) , phospholipase A2 measurement study vasodilatory effect HDL particle .</detailed_description>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>patient type 2 diabetes treat oral antidiabetic agent ( except glitazones ) and/or insulin age &gt; 18 year HbA1c &gt; 6.5 % renal failure heart failure primary hyperlipidemia pregnancy treatment may modify lipid metabolism ( glucocorticoid , oestrogen , retinoids , HIV antiviral drug )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>diabetes</keyword>
	<keyword>glitazones</keyword>
	<keyword>HDL</keyword>
</DOC>